Evidence map›Paper›PMID 37702541›Full record

ArticleAntimicrobial agents and chemotherapy2023

Dissemination of IncI plasmid encoding

Margaux Allain, Anne Claire Mahérault, Benoit Gachet, Caroline Martinez, Bénédicte Condamine, Mélanie Magnan, Isabelle Kempf, Erick Denamur, Luce Landraud

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Margaux Allain *Université Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME , Paris, France.
Anne Claire Mahérault *Université Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME , Paris, France.
Benoit GachetUniversité Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME , Paris, France.
Caroline MartinezUniversité Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME , Paris, France.
Bénédicte CondamineUniversité Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME , Paris, France.
Mélanie MagnanUniversité Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME , Paris, France.
Isabelle KempfANSES, Laboratoire de Ploufragan-Plouzané-Niort , Ploufragan, France.
Erick DenamurUniversité Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME , Paris, France.
Luce LandraudUniversité Paris Cité and Université Sorbonne Paris Nord, INSERM, IAME , Paris, France.ORCID 0000-0001-8486-1403
Inserm · FRAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiresistance plasmids belonging to the IncI incompatibility group have become one of the most pervasive plasmid types in extended-spectrum beta-lactamase-producing

Indexed as

Escherichia coliEscherichia coli InfectionsAnimalsAnti-Bacterial Agentsbeta-LactamasesPlasmidsSwineAnti-Bacterial Agentsbeta-Lactamasesbeta-lactamase TEM-3CTX-MESBLfitness costIncI plasmidRNA-Seq

Identifiers

PMID37702541
PMCPMC10583664
OpenAlexW4386704131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.